Erasca (ERAS) Operating Expenses (2020 - 2026)
Erasca (ERAS) posted Operating Expenses of $187.9 million for Q1 2026, up 476.34% on a QoQ basis from $32.6 million in Q4 2025, and up 427.4% year-over-year from $35.6 million in Q1 2025.
Erasca (ERAS) Operating Expenses (2020 - 2026) Analysis & Trends
Erasca's Operating Expenses history runs 7 years deep, the most recent figure standing at $187.9 million for Q1 2026.
- Quarterly Operating Expenses rose 427.4% year-over-year to $187.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $293.2 million (up 66.24% YoY) and the FY2025 annual result came in at $140.9 million, down 21.54% from the prior year.
- Operating Expenses was $187.9 million for Q1 2026 at Erasca, up from $32.6 million in the prior quarter.
- Across five years, Operating Expenses topped out at $187.9 million in Q1 2026 and bottomed at $32.6 million in Q4 2025.
- A 5-year average of $52.8 million and a median of $36.5 million in 2022 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2023 — Operating Expenses slumped 75.47% — and 2026, when it surged 427.4%.
- Erasca's Operating Expenses stood at $138.1 million in 2022, then slumped by 75.47% to $33.9 million in 2023, then increased by 5.43% to $35.7 million in 2024, then retreated by 8.7% to $32.6 million in 2025, then surged by 476.34% to $187.9 million in 2026.
- Business Quant data shows ERAS's Operating Expenses at $187.9 million in Q1 2026, $32.6 million in Q4 2025, and $34.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.10 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.78 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 2.89 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 445.22 Mn |
| 10 | Erasca | 5.89 Bn | 5.89 Bn | - | 187.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 187.91 Mn |
| Dec 31, 2025 | 32.60 Mn |
| Sep 30, 2025 | 34.55 Mn |
| Jun 30, 2025 | 38.13 Mn |
| Mar 31, 2025 | 35.63 Mn |
| Dec 31, 2024 | 35.71 Mn |
| Sep 30, 2024 | 37.24 Mn |
| Jun 30, 2024 | 67.78 Mn |
| Mar 31, 2024 | 38.85 Mn |
| Dec 31, 2023 | 33.87 Mn |
| Sep 30, 2023 | 34.66 Mn |
| Jun 30, 2023 | 35.97 Mn |
| Mar 31, 2023 | 37.03 Mn |
| Dec 31, 2022 | 138.08 Mn |
| Sep 30, 2022 | 36.96 Mn |
| Jun 30, 2022 | 35.91 Mn |
| Mar 31, 2022 | 36.51 Mn |
| Dec 31, 2021 | 31.05 Mn |
| Sep 30, 2021 | 46.04 Mn |
| Jun 30, 2021 | 28.18 Mn |